Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S5SG
|
||||
Former ID |
DNC007248
|
||||
Drug Name |
2-morpholino-6-(thiophen-3-yl)-4H-pyran-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528738] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H13NO3S
|
||||
Canonical SMILES |
C1COCCN1C2=CC(=O)C=C(O2)C3=CSC=C3
|
||||
InChI |
1S/C13H13NO3S/c15-11-7-12(10-1-6-18-9-10)17-13(8-11)14-2-4-16-5-3-14/h1,6-9H,2-5H2
|
||||
InChIKey |
LICYALMZYZNUAP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [528738] | |
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
References | |||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.